NFKB1 and neoplasm: As known, the binding of αCD3 to CD3 can induce T cell activation and reverse T cell exhaustion by activating the calcium-NFAT/NF-κB signaling pathways, ultimately leading to lytic granule release and consequent tumor cell destruction (Figure 4M).54